Article

Preferences and health utilities related to disease and treatment features for patients with hemophilia A in Canada

2020-12-23

Abstract excerpt

<title>Abstract</title> <p><bold><italic>Background: </italic></bold>Hemophilia A is caused by a mutation of clotting factor genes resulting in a deficiency of factor VIII (FVIII). Current treatments for hemophilia A in Canada include on-demand treatment as bleeds occur and regular intravenous prophylactic FVIII infusions. The subcutaneous therapy emicizumab was recently approved for the treatment of hemophilia A...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a3698c32-af7e-587a-b28e-aa479ba44187
DOI: 10.21203/rs.3.rs-133513/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Preferences and health utilities related to disease and treatment features for patients with hemophilia A in CanadaDOI 10.21203/rs.3.rs-133513/v1Read

Patient preferences for gene therapy in haemophilia: Results from the PAVING threshold technique surveySemantic proximity Read

The association between health utility and joint status among people with severe haemophilia A: findings from the KAPPA register.Semantic proximity Read

Using the OPUF approach to create a value set for the EQ-HWB-S: An exploratory feasibility studySemantic proximity Read

Systematic review of health state utility values used in pharmacoeconomic evaluations for chronic hepatitis C: impact on cost-effectiveness resultsSemantic proximity Read

Using the OPUF approach to create a value set for the EQ-HWB-S: An exploratory feasibility studySemantic proximity Read

Patient and physician preferences for the treatment of chronic hepatitis C virus infections: does the perspective matter?Semantic proximity Read

Patient, consumer and societal values, perceptions and preferences on high-cost gene therapiesSemantic proximity Read

Post-operative anticoagulation therapy after knee or hip replacement: The role of patients’ preferences in selection of therapySemantic proximity Read

Health Utility of Facial Angiofibroma associated with Tuberous Sclerosis ComplexSemantic proximity Read

Preferences for genetic interventions for SCA and Huntington’s disease: results of a discrete choice experiment among patients.Semantic proximity Read

Patient satisfaction and experience with intravenously administered C1-inhibitor concentrates in the United States.Semantic proximity Read

Age and severity in relation to the quality of life among children with hemophilia: A cross-sectional studySemantic proximity Read